The number of people using oral GLP-1 medications is expected to grow rapidly over the coming years. According to a report from Food Business News, a consultancy suggests that the active user base could increase by as much as 50 per cent by 2027.
This expansion reflects a growing trend in the adoption of these specific treatments, potentially altering consumer habits and dietary needs on a large scale.
